Fidelity Investments’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7K | Buy |
19,123
+10,377
| +119% | +$12.9K | ﹤0.01% | 4230 |
|
|
2025
Q1 | $10.3K | Sell |
8,746
-13,907
| -61% | -$16.4K | ﹤0.01% | 4483 |
|
|
2024
Q4 | $41.5K | Sell |
22,653
-385,498
| -94% | -$705K | ﹤0.01% | 3928 |
|
|
2024
Q3 | $694K | Buy |
408,151
+353,092
| +641% | +$600K | ﹤0.01% | 2733 |
|
|
2024
Q2 | $75.4K | Sell |
55,059
-797,848
| -94% | -$1.09M | ﹤0.01% | 3421 |
|
|
2024
Q1 | $3.2M | Sell |
852,907
-2,872,147
| -77% | -$10.8M | ﹤0.01% | 2191 |
|
|
2023
Q4 | $36.5M | Sell |
3,725,054
-897,866
| -19% | -$8.81M | ﹤0.01% | 1411 |
|
|
2023
Q3 | $38.6M | Buy |
4,622,920
+892,145
| +24% | +$7.45M | ﹤0.01% | 1339 |
|
|
2023
Q2 | $49.6M | Sell |
3,730,775
-637,392
| -15% | -$8.48M | ﹤0.01% | 1278 |
|
|
2023
Q1 | $50.6M | Buy |
4,368,167
+4,217,484
| +2,799% | +$48.8M | ﹤0.01% | 1261 |
|
|
2022
Q4 | $1.23M | Sell |
150,683
-37,617
| -20% | -$308K | ﹤0.01% | 2497 |
|
|
2022
Q3 | $1.09M | Sell |
188,300
-1,032,423
| -85% | -$5.99M | ﹤0.01% | 2580 |
|
|
2022
Q2 | $5.4M | Sell |
1,220,723
-258,710
| -17% | -$1.14M | ﹤0.01% | 2216 |
|
|
2022
Q1 | $13.5M | Sell |
1,479,433
-312,858
| -17% | -$2.85M | ﹤0.01% | 1993 |
|
|
2021
Q4 | $36.7M | Buy |
1,792,291
+1,528,880
| +580% | +$31.3M | ﹤0.01% | 1554 |
|
|
2021
Q3 | $6.73M | Buy |
263,411
+73
| +0% | +$1.87K | ﹤0.01% | 2270 |
|
|
2021
Q2 | $9.21M | Sell |
263,338
-2,712,824
| -91% | -$94.9M | ﹤0.01% | 2138 |
|
|
2021
Q1 | $99.1M | Buy |
2,976,162
+2,975,982
| +1,653,323% | +$99.1M | 0.01% | 1071 |
|
|
2020
Q4 | $5K | Buy |
180
+129
| +253% | +$3.58K | ﹤0.01% | 3449 |
|
|
2020
Q3 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 3590 |
|
|
2015
Q1 | – | Sell |
-60,000
| Closed | -$470K | – | 2780 |
|
|
2014
Q4 | $470K | Buy |
+60,000
| New | +$470K | ﹤0.01% | 2651 |
|